Benjamin J. Hindson, President and Chief Scientific Officer, Director at 10x Genomics, holds 345.70K shares in 10x Genomics (Ticker: TXG). Most recently, Benjamin J. Hindson Sold $4,351 shares of 10x Genomics on Aug 26, 2024 for an estimated value of 97.98K.
What is the percentage of profitable transactions made by Benjamin J. Hindson?
The percentage of profitable transactions made by Benjamin J. Hindson is 79%.
What is the average return per transaction made by Benjamin J. Hindson?
The average return per transaction made by Benjamin J. Hindson is 35.90%.
What stocks does Benjamin J. Hindson hold?
Benjamin J. Hindson holds: TXG stocks.
What was Benjamin J. Hindson’s latest transaction?
Benjamin J. Hindson latest transaction was an Informative Sell of $97.98K.
What was Benjamin J. Hindson's most profitable transaction?
Benjamin J. Hindson’s most profitable transaction was an Informative Sell of TXG stock on August 25, 2021. The return on the trade was 76.80%.
What is Benjamin J. Hindson's role in 10x Genomics?
Benjamin J. Hindson's role in 10x Genomics is President and Chief Scientific Officer, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.